These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 9450795)

  • 1. Epoetin alfa and beta differ in their erythropoietin isoform compositions and biological properties.
    Storring PL; Tiplady RJ; Gaines Das RE; Stenning BE; Lamikanra A; Rafferty B; Lee J
    Br J Haematol; 1998 Jan; 100(1):79-89. PubMed ID: 9450795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lectin-binding assays for the isoforms of human erythropoietin: comparison of urinary and four recombinant erythropoietins.
    Storring PL; Tiplady RJ; Gaines Das RE; Rafferty B; Mistry YG
    J Endocrinol; 1996 Sep; 150(3):401-12. PubMed ID: 8882159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of erythropoietin biosimilars Epotin™, Hemax® and Jimaixin™ by electrophoretic methods used for doping control analysis and specific N-glycan analysis revealed structural differences from original epoetin alfa drug Eprex®.
    Capdeville P; Martin L; Cholet S; Damont A; Audran M; Ericsson M; Fenaille F; Marchand A
    J Pharm Biomed Anal; 2021 Feb; 194():113750. PubMed ID: 33234415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Erythropoiesis stimulating agents and techniques: a challenge for doping analysts.
    Jelkmann W
    Curr Med Chem; 2009; 16(10):1236-47. PubMed ID: 19355882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural analysis of the glycosylation of gene-activated erythropoietin (epoetin delta, Dynepo).
    Llop E; Gutiérrez-Gallego R; Segura J; Mallorquí J; Pascual JA
    Anal Biochem; 2008 Dec; 383(2):243-54. PubMed ID: 18804089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycoengineering of Chinese hamster ovary cells for enhanced erythropoietin N-glycan branching and sialylation.
    Yin B; Gao Y; Chung CY; Yang S; Blake E; Stuczynski MC; Tang J; Kildegaard HF; Andersen MR; Zhang H; Betenbaugh MJ
    Biotechnol Bioeng; 2015 Nov; 112(11):2343-51. PubMed ID: 26154505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative pharmacokinetics and pharmacodynamics of epoetin alfa and epoetin beta.
    Halstenson CE; Macres M; Katz SA; Schnieders JR; Watanabe M; Sobota JT; Abraham PA
    Clin Pharmacol Ther; 1991 Dec; 50(6):702-12. PubMed ID: 1752115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of epoetin alfa on the central nervous system.
    Cerami A; Brines ML; Ghezzi P; Cerami CJ
    Semin Oncol; 2001 Apr; 28(2 Suppl 8):66-70. PubMed ID: 11395856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Doping control of biosimilar epoetin kappa and other recombinant erythropoietins after intravenous application.
    Okano M; Sato M; Kaneko E; Kageyama S
    Drug Test Anal; 2011; 3(11-12):798-805. PubMed ID: 22012825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biochemical assessment of erythropoietin products from Asia versus US Epoetin alfa manufactured by Amgen.
    Park SS; Park J; Ko J; Chen L; Meriage D; Crouse-Zeineddini J; Wong W; Kerwin BA
    J Pharm Sci; 2009 May; 98(5):1688-99. PubMed ID: 18781649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant erythropoietin in humans has a prolonged effect on circulating erythropoietin isoform distribution.
    Aachmann-Andersen NJ; Just Christensen S; Lisbjerg K; Oturai P; Meinild-Lundby AK; Holstein-Rathlou NH; Lundby C; Vidiendal Olsen N
    PLoS One; 2014; 9(10):e110903. PubMed ID: 25335123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The International Standard for Recombinant DNA-derived Erythropoietin: collaborative study of four recombinant DNA-derived erythropoietins and two highly purified human urinary erythropoietins.
    Storring PL; Gaines Das RE
    J Endocrinol; 1992 Sep; 134(3):459-84. PubMed ID: 1402553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of recombinant human erythropoietin in urine by isoelectric focusing.
    Breidbach A; Catlin DH; Green GA; Tregub I; Truong H; Gorzek J
    Clin Chem; 2003 Jun; 49(6 Pt 1):901-7. PubMed ID: 12765986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics and pharmacodynamics of once-weekly subcutaneous epoetin alfa in critically ill patients: results of a randomized, double-blind, placebo-controlled trial.
    Vincent JL; Spapen HD; Creteur J; Piagnerelli M; Hubloue I; Diltoer M; Roman A; Stevens E; Vercammen E; Beaver JS
    Crit Care Med; 2006 Jun; 34(6):1661-7. PubMed ID: 16607233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stability, potency, and preservative effectiveness of epoetin alfa after addition of a bacteriostatic diluent.
    Corbo DC; Suddith RL; Sharma B; Naso RB
    Am J Hosp Pharm; 1992 Jun; 49(6):1455-8. PubMed ID: 1529989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quality and Batch-to-Batch Consistency of Original and Biosimilar Epoetin Products.
    Halim LA; Brinks V; Jiskoot W; Romeijn S; Haselberg R; Burns C; Wadhwa M; Schellekens H
    J Pharm Sci; 2016 Feb; 105(2):542-550. PubMed ID: 26869417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pain at the injection site of subcutaneously administered erythropoietin: phosphate-buffered epoetin alpha compared to citrate-buffered epoetin alpha and epoetin beta.
    Veys N; Dhondt A; Lameire N
    Clin Nephrol; 1998 Jan; 49(1):41-4. PubMed ID: 9491285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Longer-term outcomes of darbepoetin alfa versus epoetin alfa in patients with ESRD initiating hemodialysis: a quasi-experimental cohort study.
    Winkelmayer WC; Chang TI; Mitani AA; Wilhelm-Leen ER; Ding V; Chertow GM; Brookhart MA; Goldstein BA
    Am J Kidney Dis; 2015 Jul; 66(1):106-13. PubMed ID: 25943715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structures of sialylated oligosaccharides of human erythropoietin expressed in recombinant BHK-21 cells.
    Nimtz M; Martin W; Wray V; Klöppel KD; Augustin J; Conradt HS
    Eur J Biochem; 1993 Apr; 213(1):39-56. PubMed ID: 8477709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroprotective properties of epoetin alfa.
    Cerami A; Brines M; Ghezzi P; Cerami C; Itri LM
    Nephrol Dial Transplant; 2002; 17 Suppl 1():8-12. PubMed ID: 11812906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.